J. Raoul

Hepatology · 2008–2018

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Raoul trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jordi Bruix1 , 2 (in Hepatology)
  2. J. Llovet (in Hepatology)

Papers from J. Raoul's perspective

Ordered by how strongly the researchers J. Raoul trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
  2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  3. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  4. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  5. INCIDENCE OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED RISK FACTORS IN HEPATITIS C-RELATED ADVANCED LIVER DISEASE (Gastroenterology)
  6. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
  7. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. (American Journal of Epidemiology)
  8. Use of archived specimens in evaluation of prognostic and predictive biomarkers. (Journal of the National Cancer Institute)
  9. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
  10. Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity (International Journal of Cancer)

Their papers